About Rheonix
Rheonix is a company based in Ithaca (United States) founded in 2008.. Rheonix has raised $72.72 million across 23 funding rounds from investors including NIH, HHS and New York State Energy Research and Development Authority. The company has 109 employees as of December 31, 2022. Rheonix operates in a competitive market with competitors including Phoremost, 64x Bio, Nanna Therapeutics, Adaptyv Biosystems and reMYND, among others.
- Headquarter Ithaca, United States
- Employees 109 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$00as on Feb 14, 2012
-
Net Profit
-
EBITDA
-
Total Equity Funding
$72.72 M (USD)
in 23 rounds
-
Latest Funding Round
$28.6 M (USD), Series B
Oct 09, 2015
-
Investors
NIH
& 12 more
-
Employee Count
109
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Rheonix
Rheonix has successfully raised a total of $72.72M across 23 strategic funding rounds. The most recent funding activity was a Series B round of $28.6 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 23
- Last Round Series B — $28.6M
-
First Round
First Round
(01 Feb 2008)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2015 | Amount | Series B - Rheonix | Valuation | Advantage Capital , Gefinor Capital |
|
| Feb, 2015 | Amount | Grant - Rheonix | Valuation |
investors |
|
| Apr, 2014 | Amount | Grant - Rheonix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rheonix
Rheonix has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and New York State Energy Research and Development Authority. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm
|
Founded Year | Domain | Location | |
|
Gefinor Capital is engaged in private equity and asset management.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rheonix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rheonix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rheonix Comparisons
Competitors of Rheonix
Rheonix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Phoremost, 64x Bio, Nanna Therapeutics, Adaptyv Biosystems and reMYND, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Phenotypic screening platform developed to identify drug targets and pathways.
|
|
| domain | founded_year | HQ Location |
Cell and gene therapies for multiple diseases are developed.
|
|
| domain | founded_year | HQ Location |
In-vitro directed evolution platform is provided for drug discovery.
|
|
| domain | founded_year | HQ Location |
Protein design, synthesis, testing, and validation services are offered.
|
|
| domain | founded_year | HQ Location |
Developer of a drug pipeline programs for neurodegenerative diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rheonix
Frequently Asked Questions about Rheonix
When was Rheonix founded?
Rheonix was founded in 2008.
Where is Rheonix located?
Rheonix is headquartered in Ithaca, United States. It is registered at Ithaca, New York, United States.
Is Rheonix a funded company?
Rheonix is a funded company, having raised a total of $72.72M across 23 funding rounds to date. The company's 1st funding round was a Grant of $189.65K, raised on Feb 01, 2008.
How many employees does Rheonix have?
As of Dec 31, 2022, the latest employee count at Rheonix is 109.
What does Rheonix do?
Rheonix was founded in 2008 in Ithaca, United States, within the biotechnology sector. Automated assay instruments, including the flagship Chemistry and Reagent Device (CARD), are produced to utilize disposable cartridges. Molecular diagnostics for human and veterinary health, as well as food safety applications, are supported through these operations. The companys domain is rheonix.com, focusing on streamlined laboratory processes.
Who are the top competitors of Rheonix?
Who are Rheonix's investors?
Rheonix has 13 investors. Key investors include NIH, HHS, New York State Energy Research and Development Authority, U.S. Environmental Protection Agency, and Rand Capital.